Don’t forget you can visit MyAlerts to manage your alerts at any time.
Delaware Business Court Insider
By Tom McParland | October 2, 2018
The Delaware Court of Chancery on Monday allowed Fresenius SE to walk away from its planned $4.3 billion deal to acquire generic drugmaker Akorn Inc., ruling that a series of regulatory compliance issues at Akorn had allowed Fresenius to terminate the merger.
1 minute read
By Dan Packel | September 28, 2018
The joint venture went from an Obama-era glimmer to a done deal despite tumultuous politics in both countries.
1 minute read
By Sue Reisinger | September 27, 2018
"There is much to do, with many opportunities ahead, and I look forward to rolling up my sleeves and working with the executive team to build the business,” Partridge said in a statement.
1 minute read
By Max Mitchell | September 25, 2018
The policy implications of whether taking a drug during pregnancy constitutes child abuse are vast and could implicate everything from the definition…
1 minute read
By Christine Sexton | September 24, 2018
State officials said that more than 92,000 health care providers had registered to use an electronic database that tracks patients who are prescribed controlled substances.
1 minute read
By Jenna Greene | September 21, 2018
The fight between Teva and United Healthcare—which turned in large part on a he-said-she-said dispute with a client about authority to sign a settlement agreement—should scare every lawyer.
1 minute read
By Charles Toutant | September 19, 2018
The ruling came in a suit filed on behalf of a putative class made up of labor unions, insurance companies and other indirect purchasers who say they are charged more for Effexor XR due to various anti-competitive tactics by Wyeth, which is a subsidiary of Pfizer, and Teva.
1 minute read
By Max Mitchell | September 19, 2018
U.S. District Judge Mitchell Goldberg of the Eastern District of Pennsylvania ruled Wednesday that a 2015 memorandum of understanding between United HealthCare Services and three drug companies was binding.
1 minute read
By Scott D. Locke | September 19, 2018
The recent decision 'In re Rembrandt Technologies LP Patent Litigation' is a reminder of both the potential consequence of a patent holder's disingenuous assertion of unintentionality and the challenges that defendants face when raising the improper filing of a petition to revive a lapsed patent as a defense.
1 minute read
By Lizzy McLellan | September 17, 2018
Montgomery McCracken's former chairman is among the group launching St. Louis-based Armstrong Teasdale's first East Coast office.
1 minute read
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS